Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

HIV Infection

Free Subscription Articles published in Antivir Ther Retrieve available abstracts of 8 articles: HTML format

Single Articles

June 2025
1. GAO Y, Ji W, Chen Q
   The diagnostic significance of the C-reactive protein (CRP) in HIV/TB coinfection: A systematic review and meta-analysis.
   Antivir Ther. 2025;30:13596535251345870.
   PubMed     Abstract available
   
   
   
2. VAN HEMELRYCK S, Van Landuyt E, Deleu S, Leopold L, et al
   Pediatric darunavir/cobicistat fixed-dose combination tablet for dispersion: Bioequivalence versus separate agents in healthy participants and acceptability in children living with human immunodeficiency virus-1.
   Antivir Ther. 2025;30:13596535251349336.
   PubMed     Abstract available
   
   
   April 2025
3. ELEJE GU, Usman HA, Onubogu CU, Fiebai PO, et al
   Seroprevalence, seroconversion, and mother-to-child transmission of dual and triplex infections of HIV, HBV, and HCV among Nigerian obstetric population: A national multicentre prospective cohort study.
   Antivir Ther. 2025;30:13596535251333259.
   PubMed     Abstract available
   
   
   
4. PALLANZA M, Thoueille P, Briki M, Alves Saldanha S, et al
   Sustained viral suppression with once daily dolutegravir-containing regimen in presence of the strong inducer carbamazepine.
   Antivir Ther. 2025;30:13596535251335080.
   PubMed     Abstract available
   
   
   
5. LABATE L, Rossetti B, Russo C, Cassol C, et al
   Durability of multi-drug antiretroviral therapy (mega-ART) in treatment-experienced people with HIV in the ARCA database.
   Antivir Ther. 2025;30:13596535251317054.
   PubMed     Abstract available
   
   
   February 2025
6. PICKERING RT, Asundi A, Olson A, Soden K, et al
   Increased insulin resistance following switch from efavirenz to cobicistat-boosted elvitegravir.
   Antivir Ther. 2025;30:13596535251314571.
   PubMed     Abstract available
   
   
   December 2024
7. PASSEROTTO RA, Lamanna F, Salvo PF, Iannone V, et al
   Effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as switch strategy in virologically-suppressed patients: real world data from a monocentric cohort.
   Antivir Ther. 2024;29:13596535241306467.
   PubMed     Abstract available
   
   
   April 2024
8. VAN HEMELRYCK S, Van Landuyt E, Hufkens V, Vanveggel S, et al
   Assessment of swallowability and acceptability of scored darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) fixed-dose combination (FDC) tablets in HIV-1-infected children aged >/=6 to <12 years, using matching placebo tablets: A ran
   Antivir Ther. 2024;29:13596535241248282.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.